Unichem Laboratories surges on getting ANDA approval for Extended Phenytoin Sodium Capsules

Unichem Laboratories is currently trading at Rs. 368.05, up by 7.10 points or 1.97% from its previous closing of Rs. 360.95 on the BSE.

Unichem Laboratories

Unichem Laboratories

The scrip opened at Rs. 366.90 and has touched a high and low of Rs. 371.20 and Rs. 364.75 respectively. So far 8281 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 2 has touched a 52 week high of Rs. 413.55 on 21-Sep-2022 and a 52 week low of Rs. 197.50 on 22-Nov-2021.

Last one week high and low of the scrip stood at Rs. 387.10 and Rs. 347.55 respectively. The current market cap of the company is Rs. 2603.25 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 11.03% and 38.04% respectively.

Unichem Laboratories has received ANDA approval for its Extended Phenytoin Sodium Capsules USP, 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Dilantin (Phenytoin Sodium) Capsules, 100 mg, of Viatris Specialty LLC.

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. The product will be commercialized from Unichem’s Ghaziabad Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Leave a Comment